• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Spot urinary sodium for assessing dietary sodium restriction in cirrhotic ascites.用即时尿钠评估肝硬化腹水患者的饮食钠限制情况。
World J Gastroenterol. 2009 Aug 7;15(29):3631-5. doi: 10.3748/wjg.15.3631.
2
Diagnostic usefulness of the random urine Na/K ratio in predicting therapeutic response for diuretics in cirrhotic patients with ascites.随机尿钠/钾比值对肝硬化腹水患者利尿剂治疗反应的诊断价值。
J Egypt Soc Parasitol. 2013 Dec;43(3):767-76. doi: 10.12816/0006433.
3
Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites.肝硬化腹水患者尿钠/钾比值在诊断中的作用。
PLoS One. 2021 Jun 24;16(6):e0253886. doi: 10.1371/journal.pone.0253886. eCollection 2021.
4
Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio.通过简单易得的随机尿钠/钾比值预测托伐普坦的利尿反应。
PLoS One. 2017 Mar 31;12(3):e0174649. doi: 10.1371/journal.pone.0174649. eCollection 2017.
5
[Influence of non-sodium restricted diet with diuretics on plasma rennin, renal blood flow and in patients with cirrhotic ascites].[非限钠饮食联合利尿剂对肝硬化腹水患者血浆肾素、肾血流量的影响]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2013 Feb;27(1):50-3.
6
Can 24-h urine sodium excretion be replaced by spot urine sodium/potassium in patients with decompensated cirrhosis?
Liver Int. 2012 Jan;32(1):172-3. doi: 10.1111/j.1478-3231.2011.02669.x. Epub 2011 Oct 20.
7
Urinary Sodium-to-Potassium Ratio Tracks the Changes in Salt Intake during an Experimental Feeding Study Using Standardized Low-Salt and High-Salt Meals among Healthy Japanese Volunteers.在一项使用标准化低盐和高盐餐的健康日本志愿者实验性喂养研究中,尿钠钾比可跟踪盐摄入量的变化。
Nutrients. 2017 Aug 29;9(9):951. doi: 10.3390/nu9090951.
8
[The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].[速尿给药后尿钠测定在肝硬化利尿剂无反应患者中的意义]
Taehan Kan Hakhoe Chi. 2003 Dec;9(4):324-31.
9
Estimating 24-h urinary sodium/potassium ratio from casual ('spot') urinary sodium/potassium ratio: the INTERSALT Study.从随意(“点”)尿钠/钾比值估算 24 小时尿钠/钾比值:INTERSALT 研究。
Int J Epidemiol. 2017 Oct 1;46(5):1564-1572. doi: 10.1093/ije/dyw287.
10
[Use of diuretics in the treatment of ascites in patients with cirrhosis].
Acta Gastroenterol Belg. 1990 Mar-Apr;53(2):256-60.

引用本文的文献

1
[Cirrhotic cardiomyopathy – Clinically fact or academic curiosity? Review. Part 3: treatment].[肝硬化性心肌病——临床事实还是学术好奇?综述。第3部分:治疗]
Rev Fac Cien Med Univ Nac Cordoba. 2024 Sep 27;81(3):608-626. doi: 10.31053/1853.0605.v81.n3.44420.
2
Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV).奥地利共识:晚期慢性肝病中门静脉高压的诊断与管理(Billroth IV)。
Wien Klin Wochenschr. 2023 Sep;135(Suppl 3):493-523. doi: 10.1007/s00508-023-02229-w. Epub 2023 Jun 26.
3
Asia-Pacific association for study of liver guidelines on management of ascites in liver disease.亚太肝脏研究协会肝病腹水管理指南
Hepatol Int. 2023 Aug;17(4):792-826. doi: 10.1007/s12072-023-10536-7. Epub 2023 May 26.
4
Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites.肝硬化腹水患者尿钠/钾比值在诊断中的作用。
PLoS One. 2021 Jun 24;16(6):e0253886. doi: 10.1371/journal.pone.0253886. eCollection 2021.
5
INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease.国际肝脏研究协会(INASL)与国际肾脏病学会(ISN)关于肝肾同时患病患者管理的联合立场声明
J Clin Exp Hepatol. 2021 May-Jun;11(3):354-386. doi: 10.1016/j.jceh.2020.09.005. Epub 2020 Oct 9.
6
Guidelines on the management of ascites in cirrhosis.肝硬化腹水管理指南。
Gut. 2021 Jan;70(1):9-29. doi: 10.1136/gutjnl-2020-321790. Epub 2020 Oct 16.
7
Development of objective indicators for quantitative analysis of sodium intake: the sodium to potassium ratio of second-void urine is correlated with 24-hour urinary sodium excretion.钠摄入量定量分析客观指标的开发:第二次晨尿的钠钾比值与24小时尿钠排泄量相关。
Nutr Res Pract. 2020 Feb;14(1):25-31. doi: 10.4162/nrp.2020.14.1.25. Epub 2019 Nov 5.
8
Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).奥地利门静脉高压管理和治疗共识指南(Billroth III)。
Wien Klin Wochenschr. 2017 Nov;129(Suppl 3):135-158. doi: 10.1007/s00508-017-1262-3. Epub 2017 Oct 23.
9
Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio.通过简单易得的随机尿钠/钾比值预测托伐普坦的利尿反应。
PLoS One. 2017 Mar 31;12(3):e0174649. doi: 10.1371/journal.pone.0174649. eCollection 2017.
10
Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis.托伐普坦对肝硬化预后影响的预测因素
Intern Med. 2016;55(20):2911-2916. doi: 10.2169/internalmedicine.55.6819. Epub 2016 Oct 15.

本文引用的文献

1
The management of ascites and hyponatremia in cirrhosis.肝硬化腹水和低钠血症的管理
Semin Liver Dis. 2008 Feb;28(1):43-58. doi: 10.1055/s-2008-1040320.
2
Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study.血小板计数/脾脏直径比值用于食管静脉曲张的无创诊断:一项多中心、前瞻性、验证性研究的结果
Am J Gastroenterol. 2006 Nov;101(11):2511-9. doi: 10.1111/j.1572-0241.2006.00874.x. Epub 2006 Oct 4.
3
Management of refractory ascites.难治性腹水的管理
Clin Gastroenterol Hepatol. 2005 Dec;3(12):1187-91. doi: 10.1016/s1542-3565(05)00861-x.
4
The correlation between cytopenia and esophageal varices in patients with liver cirrhosis.肝硬化患者血细胞减少与食管静脉曲张之间的相关性。
Med J Malaysia. 2004 Dec;59(5):604-8.
5
Management of cirrhosis and ascites.肝硬化和腹水的管理
N Engl J Med. 2004 Apr 15;350(16):1646-54. doi: 10.1056/NEJMra035021.
6
Management of adult patients with ascites due to cirrhosis.肝硬化所致腹水成年患者的管理
Hepatology. 2004 Mar;39(3):841-56. doi: 10.1002/hep.20066.
7
[The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].[速尿给药后尿钠测定在肝硬化利尿剂无反应患者中的意义]
Taehan Kan Hakhoe Chi. 2003 Dec;9(4):324-31.
8
The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.肝硬化腹水的管理:国际腹水俱乐部共识会议报告
Hepatology. 2003 Jul;38(1):258-66. doi: 10.1053/jhep.2003.50315.
9
Management of ascites.腹水的管理
Clin Liver Dis. 2001 May;5(2):541-68, viii. doi: 10.1016/s1089-3261(05)70177-x.
10
Mechanisms of ascites formation.腹水形成的机制。
Clin Liver Dis. 2000 May;4(2):447-65. doi: 10.1016/s1089-3261(05)70118-5.

用即时尿钠评估肝硬化腹水患者的饮食钠限制情况。

Spot urinary sodium for assessing dietary sodium restriction in cirrhotic ascites.

作者信息

El-Bokl Mohammed Abdelhamid, Senousy Bahaa Eldeen, El-Karmouty Khaled Zakaria, Mohammed Inas El Khedr, Mohammed Sherif Monier, Shabana Sherif Sadek, Shalaby Hassan

机构信息

Department of Gastroenterology and Hepatology, Ain Shams University school of Medicine, Abbassia, Cairo, Egypt.

出版信息

World J Gastroenterol. 2009 Aug 7;15(29):3631-5. doi: 10.3748/wjg.15.3631.

DOI:10.3748/wjg.15.3631
PMID:19653340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2721236/
Abstract

AIM

To evaluate the accuracy of spot urinary Na/K and Na/creatinine (Cr) ratios as an alternative to 24-h urinary sodium in monitoring dietary compliance in patients with liver cirrhosis and ascites treated with diuretics.

METHODS

The study was carried on 40 patients with liver cirrhosis and ascites treated with diuretic therapy. Patients were divided into two groups according to 24-h urinary sodium. We measured spot urine Na/K ratio, Na/Cr ratio and 24-h urinary sodium. Student's t test was used to compare the interval variables and chi(2) test to compare the nominal variables between the two groups. Receiver operator characteristic curve was used to identify the best cutoff point for Na/K and Na/Cr ratio.

RESULTS

The best cutoff point for Na/K ratio was 2.5 (P < 0.001) and area under the curve (AUC) was 0.9, and for Na/Cr ratio, the best cutoff point was 35 (P < 0.001) and AUC was 0.885. Na/K ratio showed higher sensitivity and accuracy compared to Na/Cr ratio (87.5% and 87% for Na/K ratio; 81% and 85% for Na/Cr ratio, respectively).

CONCLUSION

Spot urine Na/K ratio has adequate accuracy for assessment of dietary sodium restriction compared with 24-h urinary sodium in patients with liver cirrhosis and ascites.

摘要

目的

评估随机尿钠/钾和钠/肌酐(Cr)比值作为24小时尿钠替代指标,用于监测肝硬化腹水患者利尿剂治疗期间饮食依从性的准确性。

方法

对40例接受利尿剂治疗的肝硬化腹水患者进行研究。根据24小时尿钠水平将患者分为两组。我们测量了随机尿钠/钾比值、钠/肌酐比值和24小时尿钠。采用学生t检验比较两组间的区间变量,采用卡方检验比较名义变量。采用受试者工作特征曲线确定钠/钾和钠/肌酐比值的最佳截断点。

结果

钠/钾比值的最佳截断点为2.5(P<0.001),曲线下面积(AUC)为0.9;钠/肌酐比值的最佳截断点为35(P<0.001),AUC为0.885。与钠/肌酐比值相比,钠/钾比值显示出更高的敏感性和准确性(钠/钾比值分别为87.5%和87%;钠/肌酐比值分别为81%和85%)。

结论

与24小时尿钠相比,随机尿钠/钾比值在评估肝硬化腹水患者饮食钠限制方面具有足够的准确性。